% of Cases treated with Radiotherapy
| UKIACR average (population) | UKIACR average (country) | England | Scotland | Northern Ireland | Wales | Republic of Ireland | |
|---|---|---|---|---|---|---|---|
| All invasive xnmsc | 21.2% | 20.7% | 21.4% | 20.0% | NA | ||
| All xnmsc 0-24 | 15.3% | 13.9% | 15.7% | 12.0% | NA | ||
| All xnmsc 25-59 | 24.4% | 24.4% | 24.4% | 24.3% | NA | ||
| All xnmsc 60-79 | 23.7% | 22.8% | 23.9% | 21.7% | NA | ||
| All xnmsc 80+ | 12.2% | 11.6% | 12.4% | 10.8% | NA | ||
| Haematology | 9.9% | 9.5% | 10.1% | 8.8% | NA | ||
| Head and Neck | 58.8% | 54.0% | 60.2% | 47.7% | NA | ||
| Lower GI | 13.4% | 13.5% | 13.4% | 13.5% | NA | ||
| Upper GI | 19.4% | 17.2% | 20.0% | 14.4% | NA | ||
| HPB | 2.5% | 2.5% | 2.5% | 2.4% | NA | ||
| Trachea, Bronchus & Lung | 27.5% | 28.3% | 27.3% | 29.3% | NA | ||
| Melanoma of skin | 0.9% | 0.7% | 0.9% | 0.4% | NA | ||
| Breast | 38.1% | 39.0% | 37.9% | 40.1% | NA | ||
| Cervix | 40.9% | 42.2% | 40.6% | 43.7% | NA | ||
| Other Female Genitals | 15.1% | 15.2% | 15.1% | 15.3% | NA | ||
| Prostate | 20.6% | 14.9% | 21.5% | 8.2% | NA | ||
| Kidney | 5.6% | 5.0% | 5.8% | 4.1% | NA | ||
| Bladder | 17.6% | 15.9% | 17.9% | 13.9% | NA | ||
| Brain and CNS | 47.3% | 47.2% | 47.3% | 47.0% | NA | ||
| Thyroid & other endocrine glands | 31.4% | 28.2% | 32.1% | 24.2% | NA | ||
| CUP | 12.1% | 11.5% | 12.3% | 10.7% | NA | ||
| Other invasive cancer | 16.6% | 15.3% | 17.0% | 13.6% | NA | ||
| Breast in situ | 33.2% | 37.2% | 32.5% | 41.9% | NA | ||
| Cervix in situ | 0.0% | 0.0% | 0.0% | 0.0% | NA | ||
| Other tumours | 1.1% | 0.8% | 1.3% | 0.2% | NA | ||
| Non-Melanoma Skin Cancer | 1.9% | 1.2% | 2.0% | 0.4% | NA |